VHL mutations are associated with increased expression of VHL and ubiquitin in clear cell renal cell carcinoma.

被引：0
|
作者：
Hughson, M [1 ]
He, Z [1 ]
Liu, S [1 ]
Shingleton, WB [1 ]
机构：
[1] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
来源：
MODERN PATHOLOGY | 2001年 / 14卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
641
引用
收藏
页码：111A / 111A
页数：1
相关论文
共 50 条
  • [31] VHL Mutation, VHL Methylation, Chromosome 3p and Whole Genomic Status in Clear Cell Papillary Renal Cell Carcinoma
    Martignoni, G.
    Brunelli, M.
    Segala, D.
    Borze, I.
    Atanesya, L.
    Savola, S.
    Barzon, L.
    Masi, G.
    Tardanico, R.
    Eble, J. N.
    Chilosi, M.
    Bohling, T.
    Cheng, L.
    Delahunt, B.
    Gobbo, S.
    Knuutila, S.
    LABORATORY INVESTIGATION, 2013, 93 : 233A - 233A
  • [32] Impact of belzutifan on anemia and hypoxia in sporadic and VHL-syndrome-associated renal cell carcinoma.
    do Amaral, Paulo Siqueira
    Winer, Aaron
    Beckermann, Katy
    Chen, Heidi
    Lambrecht, Morgan
    Kaiser, Elizabeth
    Rini, Brian I.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : 522 - 522
  • [33] Clinicopathological and Body Composition Analysis of VHL and TTN Gene Mutations in Clear Cell Renal Cell Carcinoma: An Exploratory Study
    Greco, Federico
    Tafuri, Alessandro
    Grasso, Rosario Francesco
    Zobel, Bruno Beomonte
    Mallio, Carlo Augusto
    APPLIED SCIENCES-BASEL, 2022, 12 (19):
  • [34] VHL Mutation, VHL Methylation, Chromosome 3p and Whole Genomic Status in Clear Cell Papillary Renal Cell Carcinoma
    Martignoni, G.
    Brunelli, M.
    Segala, D.
    Borze, I.
    Atanesya, L.
    Savola, S.
    Barzon, L.
    Masi, G.
    Tardanico, R.
    Eble, J. N.
    Chilosi, M.
    Bohling, T.
    Cheng, L.
    Delahunt, B.
    Gobbo, S.
    Knuutila, S.
    MODERN PATHOLOGY, 2013, 26 : 233A - 233A
  • [35] CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma
    McRonald, Fiona E.
    Morris, Mark R.
    Gentle, Dean
    Winchester, Laura
    Baban, Dilair
    Ragoussis, Jiannis
    Clarke, Noel W.
    Brown, Michael D.
    Kishida, Takeshi
    Yao, Masahiro
    Latif, Farida
    Maher, Eamonn R.
    MOLECULAR CANCER, 2009, 8
  • [36] Mutations of the VHL gene in sporadic renal cell carcinoma:: Definition of a risk factor for VHL patients to develop an RCC
    Gallou, C
    Joly, D
    Méjean, A
    Staroz, F
    Martin, N
    Tarlet, G
    Orfanelli, MT
    Bouvier, R
    Droz, D
    Chrétien, Y
    Maréchal, JM
    Richard, S
    Junien, D
    Béroud, C
    HUMAN MUTATION, 1999, 13 (06) : 464 - 475
  • [37] Clusterin expression differentiates wild type-VHL from VHL-defective sporadic clear cell renal cell carcinomas
    Abreu-e-Lima, P
    Sadow, PM
    Nakamura, E
    Kaelin, WG
    Nosé, V
    MODERN PATHOLOGY, 2006, 19 : 126A - 127A
  • [38] Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma
    Patard, Jean-Jacques
    Fergelot, Patricia
    Karakiewicz, Pierre I.
    Klatte, Tobias
    Trinh, Quoc-Dien
    Rioux-Leclercq, Nathalie
    Said, Jonathan W.
    Belldegrun, Arie S.
    Pantuck, Allan J.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (02) : 395 - 400
  • [39] Clusterin expression differentiates wild Type-VHL from VHL-Defective sporadic clear cell renal cell carcinomas
    Abreu-e-Lima, P
    Sadow, PM
    Nakamura, E
    Kaelin, WG
    Nosé, V
    LABORATORY INVESTIGATION, 2006, 86 : 126A - 127A
  • [40] Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation
    Greene, Christopher J.
    Sharma, Nitika J.
    Fiorica, Peter N.
    Forrester, Emily
    Smith, Gary J.
    Gross, Kenneth W.
    Kauffman, Eric C.
    FREE RADICAL BIOLOGY AND MEDICINE, 2019, 133 : 295 - 309
12345